Clinical study begins in Havana with Quimi-Vio pneumococcal vaccine for chronically ill kids
The Finlay Vaccine Institute (IFV) announced the start of a clinical study with Quimi-Vio, its vaccine candidate for the prevention of pneumonia, meningitis, otitis and sepsis caused by Streptococcus pneumoniae …
Clinical study begins in Havana with Quimi-Vio pneumococcal vaccine for chronically ill kids Read More